|
Johns Hopkins HealthCare
haploidentical hct with tcr+ t cell/cd19+ depletion Haploidentical Hct With Tcr+ T Cell/Cd19+ Depletion, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd19+depletion/haploidentical+hct+with+tcr++t+cell+cd19++depletion/10__1016_slash_s2666___6367_ascii40_23_ascii41_00464___5-61-28-36 Average 90 stars, based on 1 article reviews
haploidentical hct with tcr+ t cell/cd19+ depletion - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
ExVivo Labs
tcrαβ/cd19 depleted graft  Tcrαβ/Cd19 Depleted Graft, supplied by ExVivo Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd19+depletion/cd3+++cd19++depleted+stem+cell+grafts/pmc11535077-5-97-97 Average 90 stars, based on 1 article reviews
tcrαβ/cd19 depleted graft - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Annals of Hematology
Article Title: Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
doi: 10.1007/s00277-024-05942-2
Figure Lengend Snippet: Clinical trials and case reports of VEXAS patients who have undergone allo-HCT
Article Snippet: EBMT multicenter study [ ] , 19 , RIC-74%, MAC − 26% Fludarabine based; Flu/Bu ( n = 7), treosulfan ( n = 4), Bu/Thiotepa ( n = 3), melphalan ( n = 2), 1 received TBI), melphalan and thiotepa ( n = 1), FLAMSA/Bu- Cy sequential combination ( n = 2). , MSD: 16%, MUD: 63% MMRD: 16% MMUD: 5% , PBSC:18 BM:1 , PT Cy [day + 3/+4] n = 6, ATG [ n = 11] or alemtuzumab [ n = 2 ] + Cyclo/methotrexate [ n = 7] or MMF [ n = 5].
Techniques: Clinical Proteomics, Virus, Infection, Mutagenesis